Faron Pharmaceuticals Oy (FARN)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
155.00p
Buy
160.00p
-17.50p (-10.00%)
Prices updated at 16 Dec 2025, 15:03 GMT
| Prices minimum 15 mins delay
Prices in GBX
Faron Pharmaceuticals Oy is a clinical stage biopharmaceutical company developing novel treatments for medicalconditions. The company currently has a pipeline focusing on acute organ traumas,vascular damage and cancer immunotherapy.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
No data available
Valuation
No data available
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
| 2015 | 95.38 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | 915.92 |
| 2017 | 316.84 |
| 2016 | 65.61 |
| 2015 | 84.69 |
Price/Forward earnings (YTD)
-5.32
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -227.96 |
| 2023 | -287.97 |
| 2022 | -234.98 |
| 2021 | -196.71 |
| 2020 | -182.43 |
| 2019 | -145.65 |
| 2018 | -175.51 |
| 2017 | -137.50 |
| 2016 | -66.33 |
| 2015 | -72.86 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | 4.52 |
| 2020 | - |
| 2019 | 6.34 |
| 2018 | 21.69 |
| 2017 | 3.14 |
| 2016 | 1.87 |
| 2015 | 1.33 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
